Cytokinetics, Incorporated Underwriting Agreements
8 Contracts & Agreements
- Underwriting Agreement, dated as of May 22, 2024, by and among Cytokinetics, Incorporated, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC (Filed With SEC on May 28, 2024)
- Underwriting Agreement, dated as of July 20, 2021, by and among Cytokinetics, Incorporated, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (Filed With SEC on July 21, 2021)
- Underwriting Agreement, dated as of July 16, 2020, by and among Cytokinetics, Incorporated, Goldman Sachs & Co. LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co (Filed With SEC on July 17, 2020)
- Underwriting Agreement, dated November 7, 2019, by and between the Company and Morgan Stanley & Co. LLC as representative of the several underwriters named therein (Filed With SEC on November 13, 2019)
- 5,260,000Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT (Filed With SEC on May 9, 2017)
- 4,375,000 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT (Filed With SEC on February 20, 2014)
- 23,026 Shares of Series B Convertible PreferredStock Warrants to Purchase 13,815,600 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT (Filed With SEC on June 20, 2012)
- 55,921,055 Shares of Common Stock Warrants to Purchase 33,552,633 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENT (Filed With SEC on June 20, 2012)
